Prostate Cancer (Diagnosis) Clinical Trials

17 recruiting

Prostate Cancer (Diagnosis) Trials at a Glance

17 actively recruiting trials for prostate cancer (diagnosis) are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Algiers, Annaba, and Augsburg. Lead sponsors running prostate cancer (diagnosis) studies include Guilin Medical University, China, In Gab Jeong, MD, and Duke University.

Browse prostate cancer (diagnosis) trials by phase

Treatments under study

About Prostate Cancer (Diagnosis) Clinical Trials

Looking for clinical trials for Prostate Cancer (Diagnosis)? There are currently 17 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Prostate Cancer (Diagnosis) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Prostate Cancer (Diagnosis) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 117 of 17 trials

Recruiting
Not Applicable

Theranostic Applications of Radionuclides in Prostate Cancer

Prostate Cancer (Diagnosis)
Guilin Medical University, China100 enrolled1 locationNCT07559201
Recruiting

Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis

Prostate Cancer (Diagnosis)
Xijing Hospital1,000 enrolled9 locationsNCT07553754
Recruiting

The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center

Prostate CancerProstate Cancer (Diagnosis)
The First Affiliated Hospital of Soochow University300 enrolled1 locationNCT07552285
Recruiting

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria

Prostate CancerProstate Cancer MetastaticProstate Cancer (Adenocarcinoma)+3 more
Société Algérienne de Formation et Recherche en Oncologie2,000 enrolled24 locationsNCT07484971
Recruiting

Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy

Prostate Cancer (Adenocarcinoma)Radical ProstatectomyProstate Cancer (Post Prostatectomy)+2 more
Lithuanian University of Health Sciences500 enrolled1 locationNCT07516886
Recruiting
Phase 1

Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617

Prostate CancerLocalized Prostate CarcinomaHigh-risk Prostate Cancer+2 more
Thomas Hope45 enrolled1 locationNCT07054346
Recruiting

Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer

Prostate Cancer (Diagnosis)
Duke University300 enrolled1 locationNCT07144228
Recruiting
Not Applicable

INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis

Prostate CancerProstate Cancer (Diagnosis)
In Gab Jeong, MD1,432 enrolled1 locationNCT07398690
Recruiting
Not Applicable

Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis

Prostate Cancer (Diagnosis)
Peking University First Hospital592 enrolled1 locationNCT07460843
Recruiting
Not Applicable

Evolution of Lesions in Repeated Biparametric Prostate Magnetic Resonance Imaging

Prostate Cancer (Diagnosis)
University of Eastern Finland100 enrolled1 locationNCT07369570
Recruiting
Not Applicable

PSMA PET for Surveillance After Focal Therapy

Prostate Cancer (Adenocarcinoma)Prostate Cancer Metastatic DiseaseProstate Cancer (Diagnosis)
University of Chicago62 enrolled1 locationNCT07115914
Recruiting
Not Applicable

Assessing a Digital Exercise Intervention for Health Outcomes and Engagement in Regular Exercise

Prostate CancerProstate Cancer (Diagnosis)
Royal Marsden NHS Foundation Trust160 enrolled1 locationNCT07243834
Recruiting
Phase 2

Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)

Prostate Cancer (Diagnosis)
SMED Clinical Research60 enrolled3 locationsNCT07299292
Recruiting
Phase 1

Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe

Prostate Cancer (Diagnosis)
Johns Hopkins University60 enrolled1 locationNCT07271017
Recruiting

Virtual Biopsy of Prostate Cancer Using PSMA PET and AI

Prostate Cancer (Diagnosis)
University Hospital of North Norway220 enrolled1 locationNCT07266129
Recruiting

Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy

Prostate Cancer RecurrentProstate Cancer (Diagnosis)Prostate Cancer Patients Treated by Radiotherapy+1 more
University of Erlangen-Nürnberg Medical School200 enrolled3 locationsNCT07131956
Recruiting
Not Applicable

Prehabilitation to Patients With Prostate Cancer

Prostate Cancer (Diagnosis)
Odense University Hospital20 enrolled3 locationsNCT07162987